Sputnik V, potential COVID-19 vaccine candidate is developed by the Gamaleya National Research Centre for Epidemiology and Microbiology (GNRCEM) of the Russian Healthcare Ministry
Several vaccines required to be given in two doses. First is a half dose which starts stimulating the production of antibodies followed by the second which...
According to the Indian Council of Medical Research (ICMR), Serum Institute of India has already manufactured 40 million doses of the vaccine under the at-risk manufacturing...
Five vaccines are in advanced phases of clinical trials in India with the Serum Institute of India conducting phase-3 trial of the Oxford-Astrazeneca COVID-19 vaccine and...
According to PM Modi, India is one of the few countries where the testing and recovery rates are very high and the mortality rate is very...
According to an analysis, India is the top COVID-19 vaccine buyer followed by the European Union which has confirmed 1.58 billion doses and the US, the...
The independent Joint Committee on Vaccination and Immunisation says that those most at risk of dying from COVID-19 should be on top of the priority list...
AIIMS Director Dr Randeep Guleria expressed hope that by the end of December or early January 2021, at least one of the five COVID-19 vaccines being...
According to Health and Medical Education Minister, 26,000 people were being administered the vaccine with 1,600-1,800 people being vaccinated on a trial basis in Karnataka
According to an official release, the Chief Minister made this announcement at the virtual Cabinet meeting during a presentation to discuss the COVID-19 situation in Punjab
According to Prime Minister Boris Johnson,medicine authority's approval to COVID-19 vaccine is a ray of hope amid the gloom of the novel coronavirus which has killed...
Indian Council of Medical Research’s Director General Balram Bhargava said, the purpose is to break the chain of transmission of Novel Coronavirus and if that happens...
